Bridgewater Associates’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Bridgewater Associates's TAK Position: Q3 2026 in Review
Bridgewater Associates opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 21,276 shares worth $387K. The stake represents ﹤0.01% of the portfolio and ranks #913 among its holdings.
400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Bridgewater Associates held 21,276 shares of Takeda Pharmaceutical worth $387K as of Q3 2026.
- Takeda Pharmaceutical was a new Bridgewater Associates position in Q3 2026.
- Takeda Pharmaceutical made up ﹤0.01% of Bridgewater Associates's portfolio in Q3 2026, its #913 holding.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.